Pregnancy Complications from Herceptin, PERJETA, and KADCYLA

Contact Us to Start Enrollment

Disclaimer

Thank you for submitting your email information.

A registry representative will be in touch with you to finalize enrollment details and respond to any question you may have.

What is the MotHER Pregnancy Registry?

What is the MotHER Pregnancy Registry?

The MotHER Pregnancy Registry* is a U.S.-based, prospective, observational study of women with breast cancer who were treated with Herceptin® (trastuzumab), PERJETA® (pertuzumab), or KADCYLA® (ado-trastuzumab emtansine) during pregnancy or within seven months prior to conception.

The objective of this study is to describe adverse pregnancy complications, pregnancy outcomes, and fetal/infant outcomes in women with breast cancer treated with these therapies during pregnancy or within seven months prior to conception.

Enroll My Patient Why Should I Enroll
My Patients?

*The MotHER Pregnancy Registry is sponsored by Genentech, Inc.